Genetic Link Found Between Epstein-Barr Virus and MS

Researchers identified 39 genetic sites where the virus overlaps with MS risk, offering clues for future prevention strategies.

Updated on Oct. 26, 2026 in Stroke

A close-up view of microscopic cellular structures inside a glass petri dish, representing modern medical genetic research.
Researchers have discovered significant genetic overlap between the Epstein-Barr virus and multiple sclerosis, identifying 39 genetic sites that could refine prevention strategies. AI Illustration. Upload story photo >

Live Poll

Does new genetic research on viruses and chronic disease improve your trust in medical science?

Researchers have identified a significant genetic overlap between the Epstein-Barr virus and multiple sclerosis, offering new insights into how the virus may contribute to the condition. This discovery highlights specific genetic loci that link viral activity to immune-related risk factors for the disease.

Why it matters

Understanding the biological connection between this common virus and multiple sclerosis could eventually refine strategies for disease prevention and treatment. By mapping these genetic interactions, scientists are working to clarify how viral infection influences the body's immune response in people at risk.

A genome-wide association study of 617,186 individuals identified 39 genetic loci where Epstein-Barr virus activity overlaps with multiple sclerosis risk genes. Single-cell profiling of 38 individuals further revealed 1,069 EBV-infected B cells, confirming they upregulate genes associated with T-cell activation.

The players

Yale School of Medicine

A leading academic research institution involved in mapping the genetic foundations of autoimmune diseases and viral pathology.

The details

The study utilized whole-genome sequencing to track EBV DNA and Mendelian randomization to evaluate the contribution of viral activity to disease risk. Researchers found that latent EBV-infected B cells are particularly enriched in memory and antibody-secreting cell populations. These cells are capable of upregulating MS risk genes and activating costimulatory programs that influence T-cell behavior, potentially driving the immune dysfunction seen in multiple sclerosis.

Timeline

  1. October 21-23, 2026: Researchers presented the study findings at the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto.

Health Landscape

This study advances the ongoing investigation into the Epstein-Barr virus and multiple sclerosis link by providing a molecular map of shared genetic risks. It builds upon previous longitudinal data showing that individuals infected with the virus face a 32-fold increased risk of developing the disease.

This research is currently in the discovery phase and does not change immediate treatment protocols for those already diagnosed with multiple sclerosis. If you have concerns about personal risk factors or family history, these findings provide a basis for informed conversations with a neurologist.

The takeaway

The link between the Epstein-Barr virus and multiple sclerosis is increasingly supported by genetic evidence, suggesting the virus plays a role in immune system dysregulation. Patients interested in the latest developments in autoimmune research can continue to discuss new findings with their care teams.

Further reading

For more on the biological factors influencing neurological conditions, visit our Stroke section.

Source note: This article includes information reported by Neurologylive.

Live Poll

Does new genetic research on viruses and chronic disease improve your trust in medical science?